fda compounding semaglutide crackdown 2025 news September 2, 2025: U.S. restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines FDA bans compounded weight loss

Running alongside these is TRIUMPH-CVOT, a separate cardiovascular outcomes trial enrolling around 10,000 participants with established cardiovascular disease over 3-4 years

Watch for these warning signs: Persistent body image concerns affecting daily activities Anxiety about medication effectiveness or access Difficulty adapting to physical changes Social withdrawal or isolation Increased stress about weight management Persistent negative thoughts about self-worth Healthcare experts recommend seeking professional help if these symptoms persist for more than two weeks or begin interfering with daily activities

Bangerter-Rhyner Foundation, and a top-up stipend from the PhD Program Health Sciences, University Hospital Basel, Switzerland (to COS)

Appetite and Eating It is expected that your appetite will be suppressed significantly